NSG Bio and Charles River Sign Memorandum of Understanding to Strengthen Support for Biotech Innovation in Singapore
Partnership to expand ecosystem connectivity, expertise access, and enablement for life sciences companies SINGAPORE, April 9, 2026 /PRNewswire/ -- NSG Bio announced the signing of a Memorandum of Understanding (MOU) with Charles River Laboratories...
Locus Cell, Taiwan-Based Cell and Gene Therapy CDMO, Signs MoU with Charles River at APAC Biomanufacturing Leadership Summit
SINGAPORE, March 12, 2026 /PRNewswire/ -- Locus Cell Co., Ltd. ("Locus Cell"), a Taiwan-based cell and gene therapy (CGT) Contract Development and Manufacturing Organization (CDMO), and Charles River Laboratories ("Charles River"), a global contract...